Jane Street’s Tango Therapeutics TNGX Stock Holding History

Jane Street’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.1M	Buy	+514,265	New	+$12.7M	﹤0.01%	2352
2025 Q2	–	Sell	-352,897	Closed	-$483K	–	10896
2025 Q1	$483K	Buy	352,897 +257,668	+271%	+$633K	﹤0.01%	6925
2024 Q4	$294K	Buy	95,229 +44,465	+88%	+$206K	﹤0.01%	7770
2024 Q3	$391K	Sell	50,764 -18,126	-26%	-$173K	﹤0.01%	7603
2024 Q2	$591K	Buy	68,890 +16,262	+31%	+$126K	﹤0.01%	6736
2024 Q1	$418K	Sell	52,628 -33,596	-39%	-$360K	﹤0.01%	7006
2023 Q4	$854K	Buy	+86,224	New	+$748K	﹤0.01%	5852
2023 Q3	–	Sell	-20,592	Closed	-$68.4K	–	9391
2023 Q2	$68.4K	Buy	20,592 +5,968	+41%	+$21.5K	﹤0.01%	8139
2023 Q1	$57.8K	Buy	+14,624	New	+$84.9K	﹤0.01%	8413
2022 Q2	–	Sell	-32,656	Closed	-$248K	–	10886
2022 Q1	$248K	Buy	+32,656	New	+$283K	﹤0.01%	8697

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jane Street's TNGX Position: Q2 2026 in Review

Jane Street opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 514,265 shares worth $16.1M. The stake represents ﹤0.01% of the portfolio and ranks #2352 among its holdings. This is a return to the name: Jane Street previously reported a position in TNGX as recently as Q1 2025.

Jane Street first reported a position in TNGX in Q1 2022 and has held it in 10 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Jane Street held 514,265 shares of Tango Therapeutics worth $16.1M as of Q2 2026.
Tango Therapeutics was a new Jane Street position in Q2 2026.
Tango Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2352 holding.
Jane Street first reported a position in Tango Therapeutics in Q1 2022 and has held it in 10 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.